Discussion board
AD research, diagnostic biomarkers, drug development, clinical practice — ask something specific
PinnedWorld Alzheimer Report 2026: the bottleneck is no longer the drug, it is recruitment
Alzheimer's Disease International published the World Alzheimer Report 2026 in September 2026. The theme is the new era of dementia clinical trials; it draws on interviews with more than 45 key figure…
阿阿尔茨海默病研究Lab Grunt·2 days ago·replies 0·likes 0·views 8
Can plasma p-tau217 pick out AD co-pathology in CAA? The ANGMAR cohort, n = 231
In June 2026, Alzheimer's & Dementia published the ANGMAR cohort study (Fernández-Lebrero et al., Hospital del Mar Research Institute, Barcelona).…
阿阿尔茨海默病研究Lab Grunt·3 days ago·replies 0·likes 0·views 4
Where lecanemab is covered: a 29-entry checklist of Chinese supplementary medical insurance plans
Lecanemab entered the first edition of China's Commercial Health Insurance Innovative Drug Catalogue on 1 January 2026.…
阿阿尔茨海默病研究Lab Grunt·8 days ago·replies 0·likes 0·views 9